-

OpenEvidence Integrates ASCO Guidelines, Figures and Flowcharts into Specialty Oncology Model

MIAMI--(BUSINESS WIRE)--Today, OpenEvidence, the most widely used medical knowledge platform, announced an integration of ASCO Guidelines, figures, and flowcharts into the OpenEvidence model.

“ASCO is committed to helping clinicians access our Guidelines and the evidence behind them." --Clifford A. Hudis, MD, FACP, FASCO

Share

As a part of OpenEvidence's commitment to creating advanced AI models for medical specialties, the company has extended their oncology model to include the ASCO Guidelines. ASCO Guidelines will now appear within OpenEvidence answers, accompanied by peer-reviewed evidence, precise citations, and a direct link to the ASCO website.

“ASCO is committed to helping clinicians access our Guidelines and the evidence behind them," said Clifford A. Hudis, MD, FACP, FASCO, Chief Executive Officer of ASCO. "Our license agreement with OpenEvidence makes it easier for their users to find information to help determine the next best steps in a patient's care.” The OpenEvidence team incorporated the ASCO Guidelines within its oncology model and conducted a thorough evaluation to ensure the system accurately reflects the original evidence. All responses include direct links to ASCO's source documents, allowing users to view the full guidance alongside the broader body of clinical evidence available on the OpenEvidence platform throughout the United States.

"As an oncologist, I recognize the complexity of clinical decision making as the number of treatment options multiply. Expert guidance and recommendations through algorithms and decision trees are natural for clinicians to read and interpret, but represent a challenge for language models. I’ve been excited to work directly on this project to train models to incorporate the ASCO Guidelines, figures, and flowcharts into the broader medical literature and make them more accessible to our users," said Travis Zack, MD PhD, Chief Medical Officer of OpenEvidence."

About OpenEvidence

OpenEvidence is the most widely used medical AI platform among U.S. physicians, and is trusted by hundreds of thousands of verified clinicians to make high-stakes clinical decisions at the point of care with answers that are sourced, cited, and grounded in peer-reviewed medical literature. OpenEvidence was founded with the mission to organize and expand the world's collective medical knowledge. Learn more at openevidence.com.

Contacts

OpenEvidence

Details
Headquarters: Miami, FL
CEO: Daniel Nadler
Employees: na
Organization: PRI

Release Versions

Contacts

Social Media Profiles
More News From OpenEvidence

OpenEvidence Launches Voice Mode: The First Native Speech-to-Speech Medical AI

MIAMI--(BUSINESS WIRE)--OpenEvidence, the most widely used medical AI platform among U.S. physicians, today launched Voice Mode, the first native speech-to-speech medical AI interface. With Voice Mode, OpenEvidence becomes the first multimodal medical AI offering a hands-free way for clinicians to ask questions aloud, and hear cited answers read back, on the same peer-reviewed evidence base. The feature is live in the OpenEvidence web and mobile apps and is free for all users. Physicians reach...

OpenEvidence and Society of Surgical Oncology Announce Strategic Partnership to Advance Surgical Cancer Care and Launch SSO Innovator Grant

MIAMI & ROSEMONT, Ill.--(BUSINESS WIRE)--Today, the Society of Surgical Oncology (SSO), a global professional society for cancer surgeons, and OpenEvidence, the most widely used medical knowledge platform, announced a strategic partnership to strengthen access to the most trusted surgical oncology evidence at the point of care while building a foundation for innovative collaborations to support surgeons and all physicians taking care of patients with cancer. Together, SSO and OpenEvidence will...

The Global Initiative for Asthma and OpenEvidence Partner to Deliver Asthma Strategy to Physicians Worldwide

FONTANA, Wis. & MIAMI--(BUSINESS WIRE)--The Global Initiative for Asthma (GINA) collaborates with OpenEvidence to make GINA’s evidence-based asthma strategy reports, clinical recommendations, and educational resources available directly through OpenEvidence. Under the agreement, OpenEvidence becomes a key content partner for GINA, driving the digital dissemination of asthma standards to clinicians across OpenEvidence’s rapidly expanding international footprint. Asthma affects more than 300 mill...
Back to Newsroom